Introduction Romosozumab is a humanized monoclonal antibody used for the treatment of osteoporosis in postmenopausal women who are at high risk of fracture. It is marketed under the brand name Evenity. Pharmacologically, romosozumab belongs to the sclerostin inhibitor class and is considered an anabolic bone-forming therapy with an additional antiresorptive effect. Osteoporosis is characterized by … Read more
Introduction Teriparatide is a recombinant form of the first 34 amino acids of human parathyroid hormone (PTH 1-34), which represents the biologically active portion of the hormone. It is used primarily as an anabolic agent in the treatment of osteoporosis. Teriparatide is unique among osteoporosis therapies because it stimulates new bone formation rather than merely … Read more
Introduction Alendronate is a nitrogen-containing bisphosphonate used primarily in the treatment and prevention of osteoporosis and other bone-resorptive disorders. It acts by inhibiting osteoclast-mediated bone resorption, thereby maintaining or increasing bone mineral density. Mechanism of Action (Stepwise Points) Pharmacokinetics Clinical Uses Adverse Effects Comparative Analysis Parameter Alendronate Risedronate Zoledronate Route Oral Oral IV Dosing Frequency … Read more
